Berylson Capital Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $284K | Hold |
|
|||||
|
2024
Q2 | $259K | Sell |
|
|||||
|
2024
Q1 | $393K | Hold |
|
|||||
|
2023
Q4 | $327K | Hold |
|
|||||
|
2023
Q3 | $243K | Hold |
|
|||||
|
2023
Q2 | $232K | Sell |
|
|||||
|
2023
Q1 | $1.46M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $5.27M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $4.62M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $9.25M | Sell |
|
|||||
|
2021
Q1 | $11.9M | Buy |
|
|||||
|
2020
Q4 | $12.1M | Hold |
|
|||||
|
2020
Q3 | $11.2M | Buy |
|
|||||
|
2020
Q2 | $8.61M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $977K | Buy |
|